Xiao-Feng Li Selected Research

Xiao-Feng Li Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 08/2002
28	Infections 02/2024 - 02/2009
22	Inflammation (Inflammations) 01/2024 - 06/2010
20	Rheumatoid Arthritis 01/2024 - 01/2015
19	Hypoxia (Hypoxemia) 09/2023 - 08/2002
15	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2002
14	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2013
11	Fibrosis (Cirrhosis) 02/2024 - 06/2011
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2012
9	Zika Virus Infection 01/2024 - 01/2017
9	Pain (Aches) 01/2020 - 06/2007
7	Adenocarcinoma of Lung 03/2024 - 10/2015
7	Stroke (Strokes) 05/2023 - 09/2011
7	COVID-19 03/2022 - 01/2020
7	Dengue (Dengue Fever) 01/2021 - 01/2013
6	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 05/2012
6	Japanese Encephalitis 01/2018 - 09/2012
5	Microcephaly 01/2024 - 01/2017
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2013
5	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023 - 01/2016
5	Arthritis (Polyarthritis) 02/2023 - 10/2017
5	Obesity 01/2023 - 12/2010
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2003
5	Virus Diseases (Viral Diseases) 01/2019 - 02/2007
4	Psoriatic Arthritis 02/2024 - 07/2009
4	Lymphatic Metastasis 01/2022 - 11/2012
4	Ischemic Stroke 10/2020 - 09/2015
4	Wounds and Injuries (Trauma) 11/2018 - 08/2012
4	Colonic Neoplasms (Colon Cancer) 01/2015 - 12/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 07/2003
3	Osteoporosis 11/2023 - 01/2013
3	Congenital Abnormalities (Deformity) 10/2023 - 11/2013
3	Constipation 05/2023 - 10/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2022 - 09/2015
3	Migraine Disorders (Migraine) 02/2022 - 09/2011
3	Ascites 01/2022 - 10/2013
3	Atrial Fibrillation 12/2021 - 03/2011
3	Facial Paralysis (Facial Palsy) 03/2021 - 10/2012
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2021 - 01/2016
3	Thymoma (Thymic Carcinoma) 08/2020 - 01/2009
3	Nasopharyngeal Carcinoma 01/2018 - 07/2016
3	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2003
2	Flavivirus Infections 01/2024 - 01/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 11/2023
2	Liver Diseases (Liver Disease) 10/2023 - 11/2019
2	Cognitive Dysfunction 05/2023 - 12/2016

Drug/Important Bio-Agent (IBA)

26	VaccinesIBA 02/2024 - 03/2011
26	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2003
14	Antiviral Agents (Antivirals)IBA 03/2023 - 03/2011
12	CytokinesIBA 02/2024 - 10/2017
12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2023 - 04/2010
12	pimonidazoleIBA 01/2022 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2010
8	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2009
7	Messenger RNA (mRNA)IBA 01/2024 - 02/2007
7	Interleukin-2 (IL2)IBA 01/2024 - 01/2020
7	MicroRNAs (MicroRNA)IBA 04/2021 - 10/2012
5	RNA (Ribonucleic Acid)IBA 01/2024 - 12/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2024 - 12/2015
5	Circular RNAIBA 10/2023 - 03/2018
5	Attenuated VaccinesIBA 10/2022 - 01/2018
5	CrizotinibIBA 01/2020 - 12/2017
5	Bromodeoxyuridine (BrdU)IBA 12/2013 - 08/2007
4	6-methyladenineIBA 09/2023 - 01/2021
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2023 - 12/2015
4	Oxygen (Dioxygen)IBA 01/2021 - 04/2014
4	Interferon Type IIBA 11/2020 - 05/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2016
4	LipopolysaccharidesIBA 03/2018 - 07/2010
4	Monoclonal AntibodiesIBA 09/2015 - 09/2003
3	Interleukin-17 (Interleukin 17)IBA 11/2023 - 03/2020
3	InterferonsIBA 11/2023 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 11/2023 - 01/2019
3	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 07/2009
3	hesperetinIBA 10/2022 - 05/2017
3	Neutralizing AntibodiesIBA 03/2022 - 01/2014
3	AntibodiesIBA 03/2022 - 12/2017
3	Long Noncoding RNAIBA 11/2021 - 01/2020
3	CateninsIBA 01/2021 - 11/2013
3	LipidsIBA 01/2021 - 08/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 01/2009
3	NucleotidesIBA 08/2018 - 09/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2012
3	Immunoglobulin G (IgG)IBA 04/2015 - 07/2003
3	EpitopesIBA 01/2015 - 07/2013
3	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2013 - 08/2007
3	carbogenIBA 04/2010 - 01/2007
2	xylometazoline (stas)IBA 03/2024 - 01/2024

Therapy/Procedure

45	Therapeutics 01/2024 - 12/2002
11	Drug Therapy (Chemotherapy) 01/2023 - 06/2008
9	Acupuncture Points (Acupuncture Point) 05/2023 - 09/2011
7	Percutaneous Collagen Induction 10/2022 - 10/2008
7	Acupuncture Therapy 10/2022 - 03/2014
6	Radiotherapy 01/2023 - 09/2003
4	Electroacupuncture 05/2023 - 12/2016
3	Moxibustion 10/2022 - 08/2012
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2019 - 01/2012
2	Meridians (Jing Luo) 05/2023 - 10/2022